Princeton-based Calyptus Pharmaceuticals Inc. announced Aug. 22 that it entered into an agreement with Provepharm SAS to accelerate development of its complex injectable product used in acute care ...
BRIDGEWATER, N.J., May 02, 2022 (GLOBE NEWSWIRE) -- Nevakar Injectables Inc. (“Nevakar”), a wholly owned subsidiary of Nevakar, Inc., is a biopharmaceutical company developing multiple sterile ...
(RTTNews) - Endo International Plc (ENDP) said Monday that its subsidiary, Endo Ventures Limited, has acquired six development stage, ready-to-use injectable product candidates from Nevakar ...
A magnifying glass. It indicates, "Click to perform a search". A magnifying glass. It indicates, "Click to perform a search". The word "Markets Insider". CUPERTINO, Calif., Sept. 9, 2019 /PRNewswire/ ...
Amneal announced the advancement of two key strategic initiatives. Amneal has received approval from the Food and Drug Administration for exenatide, which is the company’s first generic injectable ...
2023 was a productive year for Amneal. The company shared that it launched 39 new retail and injectable medicines in 2023, compared to 26 new launches in 2022. In the fourth quarter of 2023, Amneal ...
DUBLIN, May 2, 2022 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that its subsidiary Endo Ventures Limited (EVL) acquired six development-stage, ready-to-use injectable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback